US Broker Ratings

Evolent Health (EVH): Can This Healthcare Innovator Deliver a 154% Upside?

Evolent Health, Inc. (EVH), a healthcare innovator headquartered in Arlington, Virginia, is at a pivotal juncture that could offer a remarkable investment opportunity. With its current stock trading at $3.77..

BioLife Solutions, Inc. (BLFS): Investor Outlook with a 32.86% Potential Upside

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading player in the healthcare sector’s medical instruments and supplies industry, has been attracting considerable attention from investors. With a market capitalization of $1.18..

Azenta, Inc. (AZTA) Stock Analysis: Navigating a Healthcare Innovation with a Potential 8.75% Upside

Azenta, Inc. (NASDAQ: AZTA), a stalwart in the healthcare sector, has been making waves in the medical instruments and supplies industry. With a market capitalization of $1.84 billion, Azenta has..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: A 12.62% Upside Potential Amid Sector Growth

Healthcare Services Group, Inc. (NASDAQ: HCSG) stands out in the medical care facilities industry with a market capitalization of $1.38 billion, positioning itself as a significant player in the U.S...

Wave Life Sciences Ltd. (WVE) Stock Analysis: Biotechnology Leader with 133.86% Potential Upside

Wave Life Sciences Ltd. (NASDAQ: WVE), a Singapore-based biotechnology company, is capturing the attention of investors with its innovative approach to RNA medicine and a remarkable potential upside of 133.86%...

Supernus Pharmaceuticals (SUPN) Stock Analysis: Exploring a 22.67% Potential Upside

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a prominent player in the healthcare sector, specializes in developing and commercializing treatments for central nervous system (CNS) diseases. With a market capitalization of $2.87..

Integra LifeSciences Holdings C (IART) Growth Potential: Exploring a 24.9% Upside

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a prominent player in the healthcare sector specializing in medical devices, presents a compelling case for investors looking for growth potential within a challenging..

Investor Outlook: Novavax, Inc. (NVAX) Shows Potential 59.66% Upside Despite Challenges

Novavax, Inc. (NVAX), a pioneering player in the biotechnology sector, continues to capture the interest of investors with its innovative vaccine offerings. Headquartered in Gaithersburg, Maryland, Novavax has positioned itself..

Viridian Therapeutics, Inc. (VRDN) Investor Outlook: Unpacking a Remarkable 81,958% Revenue Growth in the Biotech Sector

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a notable player in the biotechnology sector, is catching the eye of investors with its staggering revenue growth of 81,958.10%. Specializing in the development of..

The Pennant Group, Inc. (PNTG) Investor Outlook: Analyzing a 28.64% Potential Upside in Healthcare

In the ever-evolving landscape of healthcare services, The Pennant Group, Inc. (NASDAQ: PNTG) emerges as a noteworthy player, delivering an impressive potential upside of 28.64% according to recent analyst ratings...

Arrowhead Pharmaceuticals, Inc. (ARWR)

⚠️ No article content returned.

..

PACS Group, Inc. (PACS) Stock Analysis: Strong Revenue Growth and Analyst Optimism Signal a 14% Upside Potential

PACS Group, Inc. (NASDAQ: PACS), a leader in the healthcare sector, focuses on operating skilled nursing and assisted living facilities across the United States. Despite market fluctuations, the company has..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a 22.48% Potential Upside for Investors

U.S. Physical Therapy, Inc. (NYSE: USPH) is capturing the attention of investors with a compelling potential upside of 22.48%, according to the latest analyst ratings. As a key player in..

CONMED Corporation (CNMD) Stock Analysis: Exploring a 16.43% Upside Potential for Investors

CONMED Corporation (NASDAQ: CNMD), a key player in the healthcare sector with a focus on medical devices, offers investors an intriguing opportunity. With a market cap of $1.29 billion, this..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: A Biotech Player with a 12.23% Upside Potential

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a Canadian biotech firm focused on autoimmune diseases, presents an intriguing opportunity for investors seeking exposure in the healthcare sector. With a market capitalization of..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Exploring a 19.31% Potential Upside in Healthcare

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) stands as a prominent player in the medical care facilities sector, offering a diversified range of home healthcare services across the United States. With..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: Unlocking a 35% Upside Potential

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is making waves in the biotechnology sector with its innovative focus on cellular metabolism. Headquartered in Cambridge, Massachusetts, Agios is renowned for its development of..

Janux Therapeutics, Inc. (JANX) Stock Analysis: Unveiling a Potential 362% Upside in Cutting-Edge Immunotherapy

Janux Therapeutics, Inc. (NASDAQ: JANX), a promising player in the biotechnology sector, is captivating investor attention with its innovative approach to cancer treatment. With a market capitalization of $827.63 million,..

Innoviva, Inc. (INVA) Stock Report: Uncovering a 67% Upside Potential in the Biotechnology Sector

Innoviva, Inc. (NASDAQ: INVA), a prominent player in the biotechnology sector, is currently capturing investor attention with its promising growth trajectory and significant potential upside. Based in Burlingame, California, Innoviva..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a Potential 177.99% Upside

Opko Health, Inc. (NASDAQ: OPK), a key player in the healthcare sector, is stirring interest among investors with its compelling growth potential. Despite its recent challenges, the diagnostics and pharmaceuticals..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds